SMAD3 and liver cancer: To further substantiate these findings in vivo, we performed IHC staining on liver cancer specimens induced in wild‐type and Nsun5‐KO mice, which revealed a significant reduction in Smad3 content in Nsun5−/− mice, consistent with our experimental observations (Figure 7A).